No Data
BioSig Technologies Appoints Ferdinand Groenewald as Interim CFO
BioSig Technologies (BSGM) said Monday it has appointed Ferdinand Groenewald as interim chief financial officer. Groenewald is currently the vice president of finance at Alaunos Therapeutics (TCRT), B
Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.
Alaunos Therapeutics (TCRT.US): The 2024 Q1 financial report achieved revenue of $1,000, previous value of $0; earnings per share of -0.11 dollars, previous value of -0.63 dollars.
Alaunos Therapeutics | 10-Q: Quarterly report
Alaunos Therapeutics Announces Executive Financial Leadership Changes
Alaunos Therapeutics Regains Nasdaq Listing Compliance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersCogent Biosciences (NASDAQ:COGT) shares rose 45.6% to $7.95 during Wednesday's pre-market session. The company's market cap stands at $684.6 million. Lineage Cell Therapeutics (AMEX:LCTX) stock